لخّصلي

Endometrial cancer is typically endometrioid adenocarcinoma.While endometrial adenocarcinoma is a very common gynecologic malignancy in the U.S., it has a promising prognosis since most women present with symptoms at an early stage; 4% of cancer deaths in women result from endometrial adenocarcinomaThe ACS estimates that in 2017, 61,380 new cases of endometrial cancer will be diagnosed and 10,920 women will die from the disease.

Endometrial cancer is typically endometrioid adenocarcinoma. More than 90% of patients with endometrial cancer will present with abnormal vaginal bleeding, whether it is menorrhagia, metrorrhagia, or any amount of postmenopausal bleeding; the average age at diagnosis is 61 years. The ACS estimates that in 2017, 61,380 new cases of endometrial cancer will be diagnosed and 10,920 women will die from the disease. Endometrial cancer accounts for 7% of female cancers, following breast, lung, and colorectal cancer. Incidence of endometrial cancer is greater among Caucasians when compared with Asian or African American women; however, the mortality rate is greatest among African American women. While endometrial adenocarcinoma is a very common gynecologic malignancy in the U.S., it has a promising prognosis since most women present with symptoms at an early stage; 4% of cancer deaths in women result from endometrial adenocarcinoma